US 12,031,109 B2
Hydrophilization treatment agent composition
Takayuki Nomura, Tokyo (JP); and Takanori Saito, Tokyo (JP)
Assigned to KAO CORPORATION, Tokyo (JP)
Appl. No. 17/420,170
Filed by KAO CORPORATION, Tokyo (JP)
PCT Filed Nov. 20, 2019, PCT No. PCT/JP2019/045445
§ 371(c)(1), (2) Date Jul. 1, 2021,
PCT Pub. No. WO2020/166161, PCT Pub. Date Aug. 20, 2020.
Claims priority of application No. 2019-023593 (JP), filed on Feb. 13, 2019.
Prior Publication US 2022/0089972 A1, Mar. 24, 2022
Int. Cl. C11D 1/12 (2006.01); C11D 1/62 (2006.01); C11D 1/65 (2006.01); C11D 3/00 (2006.01); C11D 3/30 (2006.01); C11D 3/34 (2006.01); C11D 1/14 (2006.01); C11D 1/28 (2006.01); C11D 1/29 (2006.01)
CPC C11D 3/0036 (2013.01) [C11D 1/12 (2013.01); C11D 1/65 (2013.01); C11D 3/30 (2013.01); C11D 3/3409 (2013.01); C11D 1/123 (2013.01); C11D 1/143 (2013.01); C11D 1/28 (2013.01); C11D 1/29 (2013.01); C11D 1/62 (2013.01); C11D 2111/18 (2024.01)] 13 Claims
 
1. A hydrophilization treatment agent composition comprising (A) a branched anionic surfactant, (B) a di-long chain hydrocarbon cationic surfactant, and water,
wherein:
a molar ratio of (B) to a total of (A) and (B), (B)/[(A)+(B)], is 0.1 or more and 0.8 or less;
(A) is one or more branched anionic surfactants selected from the group consisting of an internal olefin sulfonate salt, a secondary alkane sulfonate salt and a dialkyl sulfosuccinate salt; and
(B) is a cationic surfactant represented by the following general formula (B):

OG Complex Work Unit Chemistry
wherein two of R1b, R2b, R3b and R4b are hydrocarbon groups with 6 or more and 14 or less carbons and the remaining two are hydrocarbon groups with 1 or more and 3 or less carbons; and X− is a counter ion.